Blood pressure: the silent, fixable multiplier

Blood pressure is the quiet multiplier. It carries no symptoms until it’s done years of damage, and it feeds directly into the two things most likely to end a life early: heart attack and stroke. The good news is that it’s both easy to measure and, when elevated, genuinely treatable.

The evidence here is unusually clean. SPRINT, a large randomized trial, pushed one group’s systolic target below 120 and another below 140. The intensive group had roughly 25% fewer major cardiovascular events and 27% fewer deaths — enough that the trial was stopped early. Guidelines moved with it, redefining hypertension down to 130/80.

Measure it like it matters

A single reading in a rushed clinic visit is a poor basis for a decades-long decision. Blood pressure is variable; the number that matters is the pattern across several proper measurements — seated, rested, correct cuff, ideally some at home. Get that right before drawing conclusions.

The honest trade-off

SPRINT’s intensive arm also had more treatment-related side effects. Lower isn’t free, and the right target depends on age, frailty, and the rest of your risk picture — a decision to make with a clinician, not a slogan. Lifestyle levers (aerobic fitness, sodium, weight, alcohol, sleep — including untreated apnea) can move the number, sometimes enough to avoid medication and often enough to reduce the dose. When they’re not enough, the drugs work, and the events they prevent are worth the trade.